Name: REGENERON PHARMACEUTICALS (1REGN) Stock
Brand: REGENERON PHARMACEUTICALS
Rating: 6 (3 reviews)

Question 1

Can you describe the business of REGENERON PHARMACEUTICALS?

Accepted Answer

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. The company is headquartered in Tarrytown, New York and currently employs 15,106 full-time employees.  The firm invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The firm is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.

Question 2

What is the current price of 1REGN stock?

Accepted Answer

The current stock price of 1REGN.MI is 628.2 EUR. The price increased by 2.55% in the last trading session.

Question 3

Does 1REGN stock pay dividends?

Accepted Answer

REGENERON PHARMACEUTICALS (1REGN.MI) has a dividend yield of 0.47%. The yearly dividend amount is currently 0.

Question 4

How is the ChartMill rating for REGENERON PHARMACEUTICALS?

Accepted Answer

1REGN.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.

Question 5

Should I buy 1REGN stock?

Accepted Answer

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1REGN.MI.

Question 6

What is REGENERON PHARMACEUTICALS worth?

Accepted Answer

REGENERON PHARMACEUTICALS (1REGN.MI) has a market capitalization of 66.02B EUR. This makes 1REGN.MI a Large Cap stock.

Question 7

What is the next earnings date for 1REGN stock?

Accepted Answer

REGENERON PHARMACEUTICALS (1REGN.MI) will report earnings on 2026-02-02, after the market close.

REGENERON PHARMACEUTICALS (1REGN.MI) Stock Price, Forecast & Analysis

1REGN.MI Latest News, Press Relases and Analysis